Home > NRC Library > ADAMS Public Documents

613910 Amendment No. 5 for Nuke Med Inc. dba Spectron Rx to License No. 13-32726-02.

Accession Number: ML20042D604

Date Released: Wednesday, February 19, 2020

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20042D278 - 613909, 613910 Safety Evaluation Report re TOC Consent Request for Nuke Med Inc. dba Spectron Rx to License Nos. 13-32726-01MD, 13-32726-02. (3 page(s), 2/7/2020)
• ML20042C830 - 613909, 613910 TOC Consent and Cover Letter for Nuke Med Inc. dba Spectron Rx to License Nos. 13-32726-01MD, 13-32726-02. (3 page(s), 2/7/2020)
• ML20042C824 - 613910 Amendment No. 5 for Nuke Med Inc. dba Spectron Rx to License No. 13-32726-02. (6 page(s), 2/7/2020)
• ML19228A245 - Change of Control - Spectron mrc, LLC (13 page(s), 8/12/2019)
• ML20036D908 - Spectron mrc, LLC; Nuke Med Inc. dba Spectron Rx - Additional Information. (1 page(s), 2/5/2020)
• ML20024G146 - Spectron mrc, LLC; Nuke Med Inc. dba Spectron RX - Conversation Record and Request for Additional Information. (4 page(s), 1/24/2020)